Engineering and Development

Customer Service and Support

Management and Executive

Product Management

Sales

Marketing

Accounting and Finance

Chief Commercial Officer (CCO)

Veracyte initiated with neutral view at Canaccord, here's why

Freedom Capital Markets Initiates Coverage of Veracyte With Buy Rating and $45 Price Target

Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025

Veracyte Insider Sold Shares Worth $753,204, According to a Recent SEC Filing

Genomic Specialist

Veracyte is a global genomic diagnostics company committed to transforming cancer care. The Genomic Specialist will be responsible for customer interactions, promoting genomic diagnostic tests, and building relationships with healthcare providers to support patient care initiatives.

Genomic Specialist - Houston, TX

Vice President, Employment Law & Global HR

Sr Director, Total Rewards

Genomic Specialist, Endocrinology

Molecular Diagnostic Specialist | Regional Sales Trainer at Veracyte, INC.

Sign up with Google

Sign in with Google